A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice.
Pondugula SR, Salamat JM, Abbott KL, Flannery PC, Majrashi M, Almaghrabi M, Govindarajulu M, Ramesh S, Sandey M, Onteru SK, Huang CJ, Iwaki Y, Gill K, Narayanan N, McElroy E, Desai D, Nadar R, Moore T, Dhanasekaran M.
Pondugula SR, et al. Among authors: majrashi m.
Liver Res. 2021 Dec;5(4):239-242. doi: 10.1016/j.livres.2021.04.002. Epub 2021 May 7.
Liver Res. 2021.
PMID: 34900377
Free PMC article.